Bone Marrow TransplantationBone MarrowTissue DonorsTransplantation, HomologousLiving DonorsBone Marrow CellsKidney TransplantationGraft SurvivalGraft vs Host DiseaseWhole-Body IrradiationHistocompatibilityLiver TransplantationTransplantation ConditioningHistocompatibility TestingGraft RejectionTransplantation, AutologousLeukemiaCadaverHematopoietic Stem Cell TransplantationTransplantation ChimeraBone and BonesAnemia, AplasticRadiation ChimeraHost vs Graft ReactionHematopoietic Stem CellsLymphocyte DepletionHLA AntigensBone Marrow PurgingImmunosuppressive AgentsBone Marrow DiseasesRecurrenceBusulfanHematologic NeoplasmsLeukocyte TransfusionTreatment OutcomeMice, Inbred C57BLBlood DonorsBone Marrow ExaminationCyclophosphamideTransplantation, IsogeneicHematopoiesisLeukemia, Myeloid, AcuteSurvival AnalysisT-LymphocytesRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow NeoplasmsTime FactorsTransplantation ImmunologyCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionLeukemia, MyeloidRetrospective StudiesAcute DiseaseSevere Combined ImmunodeficiencyMyelodysplastic SyndromesGraft vs Host ReactionHepatic Veno-Occlusive DiseaseColony-Forming Units AssayBone RemodelingActuarial AnalysisStem Cell TransplantationHeart TransplantationCyclosporineLymphoma, Non-HodgkinSurvival RateChimeraAntilymphocyte SerumCord Blood Stem Cell TransplantationFollow-Up StudiesDisease-Free SurvivalCell DifferentiationDirected Tissue DonationCytomegalovirus InfectionsLung TransplantationHematologic DiseasesUnrelated DonorsPeripheral Blood Stem Cell TransplantationSpleenPancytopeniaLymphocyte TransfusionBone DensityOrgan TransplantationCells, CulturedNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFlow CytometryLeukocyte CountTissue and Organ ProcurementGranulocyte Colony-Stimulating FactorMice, Inbred BALB CGraft vs Tumor EffectCarmustineCytarabineMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34Donor SelectionBone Resorption